Psychedelic Institute of Mental Health & Family Therapy
Psychedelic Institute of Mental Health & Family Therapy
Telehealth Ketamine Therapists
⌘K
Contact
Psychedelic Institute of Mental Health & Family Therapy
michael demarco therapist

About the Psychedelic Institute of Mental Health & Family Therapy

Collaborative psychotherapy in support of medicines that may affect mental health, including ketamine
Michael DeMarco, PhD

by Michael DeMarco, PhD

About the Psychedelic Institute of Mental Health & Family Therapy
Psychedelics + Psychotherapy
PsychedelicMentalHealth.net is curated by the Psychedelic Institute of Mental Health & Family Therapy, a cognitive behavioral therapy practice specializing in multidisciplinary collaboration and continuity of care in psychotherapy plus pharmacological medicine approaches
Psychedelic Institute of Mental Health & Family TherapyPlanetMedicines

Updating to our new home on ghost.io. Find out more

Referral

Harm Reduction

Founder, Michael DeMarco- therapist

Schedule Psychedelic Therapy Telehealth

Psychedelic Institute of Mental Health & Family Therapy

More like this

Is ketamine a "psychedelic"?

Yes.
Spotlight: Long-term benefits of single-dose psilocybin in depressed patients with cancer (Agrawal, et al, 2025)

Spotlight: Long-term benefits of single-dose psilocybin in depressed patients with cancer (Agrawal, et al, 2025)

"These findings demonstrate robust antidepressive activity from a single 25 mg dose of psilocybin combined with psychotherapy and suggest a potentially paradigm-changing alternative to traditional antidepressants requiring further study."

Spotlight: New and emerging pharmacologic treatments for MDD (Uyar, et al, 2025)

"Clinical trials have demonstrated the ability of ketamine to quickly reduce symptoms, particularly in treatment-resistant cases, with effects noticeable within hours and lasting several days post-administration."
Spotlight: Deconstructing the trip treatment: are hallucinogenic effects critical to the therapeutic benefits of psychedelics? (Garcia-Romeu, 2025)

Spotlight: Deconstructing the trip treatment: are hallucinogenic effects critical to the therapeutic benefits of psychedelics? (Garcia-Romeu, 2025)

The relative contribution of drug vs. psychological support remains to be determined, though preliminary data indicate the therapeutic relationship can impact treatment outcomes [12], and factors such as environment, personality, and mindset can influence subjective drug effects.
Spotlight: A retrospective analysis of ketamine intravenous therapy for post-traumatic stress disorder in real-world care settings (McInnes, et al, 2025)

Spotlight: A retrospective analysis of ketamine intravenous therapy for post-traumatic stress disorder in real-world care settings (McInnes, et al, 2025)

"In a large real-world sample of 8,136 PTSD patients (87 % with comorbid depression), Ketamine Intravenous Therapy (KIT) significantly reduced PTSD and depression symptoms."

Spotlight: A Conversation About Black Mental Health and How CBT Can Be a Powerful Tool for Healing (2024)

"A growing body of research documents the effectiveness of CBT for racially diverse populations, including Black Americans."
Mastodon Mastodon